AstraZeneca AB
Research
Also recorded in the register as: ASTRAZENECA AB. These spellings have been reviewed and merged onto this page — see data/organisation-aliases.json in the repository.
- Sector
- Companies
- Agreements as applicant
- 1
- In term in September 2026
- 1
- Distinct datasets
- 4
- Files released
- 9
- Latest agreement end date
- 16 January 2027
Sector set by hand: A company, which the register files as Research. See data/organisation-sectors.json in the repository.
Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.
Agreements
| Agreement | Datasets | Files | Latest term | Status | Commercial |
|---|---|---|---|---|---|
| DAPA MI - A Registry-based, Randomised, Double-blind, Placebo-Controlled Cardiovascular Outcomes Trial DARS-NIC-433176-J8Q2S | 4 | 9 | 17 January 2026 to 16 January 2027 | In term | Yes |
Datasets named in its agreements
- Civil Registrations of Death
- Hospital Episode Statistics Admitted Patient Care (HES APC)
- NICOR Myocardial Ischaemia National Audit Project
- NICOR Myocardial Ischaemia National Audit Project (MINAP)
Cite this page
NHS England (2026) Data Uses Register, September 2026 edition, agreements naming AstraZeneca AB. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/organisations/astrazeneca-ab/ (accessed [date]).
This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.